Psychemedics Statistics
Total Valuation
Psychemedics has a market cap or net worth of $15.36 million. The enterprise value is $15.69 million.
| Market Cap | 15.36M |
| Enterprise Value | 15.69M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | May 24, 2023 |
Share Statistics
Psychemedics has 5.81 million shares outstanding. The number of shares has increased by 2.03% in one year.
| Shares Outstanding | 5.81M |
| Shares Change (YoY) | +2.03% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 22.70% |
| Owned by Institutions (%) | 22.34% |
| Float | 4.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.69 |
| Forward PS | n/a |
| PB Ratio | 2.30 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.45 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.80% and return on invested capital (ROIC) is -32.56%.
| Return on Equity (ROE) | -49.80% |
| Return on Assets (ROA) | -27.40% |
| Return on Capital (ROIC) | -32.56% |
| Revenue Per Employee | $190,500 |
| Profits Per Employee | -$35,810 |
| Employee Count | 116 |
| Asset Turnover | 1.46 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Psychemedics has paid $716,000 in taxes.
| Income Tax | 716,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.02% in the last 52 weeks. The beta is 0.70, so Psychemedics's price volatility has been lower than the market average.
| Beta (1Y) | 0.70 |
| 52-Week Price Change | -51.02% |
| 50-Day Moving Average | 2.92 |
| 200-Day Moving Average | 3.35 |
| Relative Strength Index (RSI) | 40.52 |
| Average Volume (30 Days) | 9,156 |
Short Selling Information
The latest short interest is 15,920, so 0.27% of the outstanding shares have been sold short.
| Short Interest | 15,920 |
| Short Previous Month | 14,813 |
| Short % of Shares Out | 0.27% |
| Short % of Float | 0.36% |
| Short Ratio (days to cover) | 1.25 |
Income Statement
In the last 12 months, Psychemedics had revenue of $22.10 million and -$4.15 million in losses. Loss per share was -$0.72.
| Revenue | 22.10M |
| Gross Profit | 8.41M |
| Operating Income | -2.92M |
| Pretax Income | -3.44M |
| Net Income | -4.15M |
| EBITDA | -768,000 |
| EBIT | -3.44M |
| Loss Per Share | -$0.72 |
Balance Sheet
The company has $1.96 million in cash and $2.30 million in debt, giving a net cash position of -$334,000 or -$0.06 per share.
| Cash & Cash Equivalents | 1.96M |
| Total Debt | 2.30M |
| Net Cash | -334,000 |
| Net Cash Per Share | -$0.06 |
| Equity / Book Value | 6.67M |
| Book Value Per Share | 1.15 |
| Working Capital | 2.10M |
Cash Flow
In the last 12 months, operating cash flow was -$1.48 million and capital expenditures -$157,000, giving a free cash flow of -$1.64 million.
| Operating Cash Flow | -1.48M |
| Capital Expenditures | -157,000 |
| Free Cash Flow | -1.64M |
| FCF Per Share | -$0.29 |
Margins
Gross margin is 38.07%, with operating and profit margins of -13.22% and -18.80%.
| Gross Margin | 38.07% |
| Operating Margin | -13.22% |
| Pretax Margin | -15.56% |
| Profit Margin | -18.80% |
| EBITDA Margin | -3.48% |
| EBIT Margin | -15.56% |
| FCF Margin | -7.41% |
Dividends & Yields
This stock pays an annual dividend of $0.07, which amounts to a dividend yield of 2.65%.
| Dividend Per Share | $0.07 |
| Dividend Yield | 2.65% |
| Dividend Growth (YoY) | 133.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.03% |
| Shareholder Yield | 0.62% |
| Earnings Yield | -27.05% |
| FCF Yield | -10.66% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 1, 2002. It was a reverse split with a ratio of 1:4.
| Last Split Date | Aug 1, 2002 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
Psychemedics has an Altman Z-Score of 0.8 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.8 |
| Piotroski F-Score | 4 |